Related Experiment Videos
Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes
Journal of Immunology (Baltimore, Md. : 1950)
|February 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Allelic variants of the canine heavy neurofilament (NFH) subunit and extensive phosphorylation in dogs with motor neuron disease.
Journal of comparative pathology·2005
Isolation of DNA markers informative in purebred dog families by genomic representational difference analysis (gRDA).
Mammalian genome : official journal of the International Mammalian Genome Society·2000
Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major.
European journal of immunology·2000
Long-term Nlrp3 gain-of-function mutation promotes cardiac dysfunction independent of inflammasome in mice.
Journal of immunology (Baltimore, Md. : 1950)·2026
Differential requirements for cytokine signaling and local antigen in upper versus lower respiratory tract CD8+ TRM development.
Journal of immunology (Baltimore, Md. : 1950)·2026
CTLA4 rs3087243-A-linked haplotype is associated with increased CTLA-4 expression and suppressive function in human regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
TCRαβ repertoire plasticity defines universal CD8+ T cell responses directed at influenza-specific HLA-A*02:01-PB1413-421 epitope.
Journal of immunology (Baltimore, Md. : 1950)·2026
TNFα promotes brain-predominant EAE independent of IFNγ and IL-17A in HLA-DR3 transgenic mice.
Journal of immunology (Baltimore, Md. : 1950)·2026
Transient manganese exposure reprograms bone marrow-derived macrophages toward a stable anti-inflammatory memory state.
Journal of immunology (Baltimore, Md. : 1950)·2026
Protection of Bevacizumab From Silicone Oil-Induced Inactivation by Liposomal Encapsulation.
Translational vision science & technology·2026
From immune heterogeneity to targeted therapies in IgG4-related disease.
Current opinion in rheumatology·2026